Discover
PPBT
Purple Biotech Ltd.
1.64
1 x 1.65
1 x 1.68
bid
ask
+
0.14
9.33%
01:25 PM
timesize
| Ytd | -75.08% | |
| 1y | -92.55% |
1.41
day range
1.69
1.16
52 week range
24.00
| Open | 1.43 | Prev Close | 1.50 | Low | 1.41 | High | 1.69 | Mkt Cap | 226.46K |
| Vol | 70.51K | Avg Vol | 329.06K | EPS | -20.63 | P/E | -0.08 | Forward P/E | -1.69 |
| Beta | 0.67 | Short Ratio | 0.43 | Inst. Own | 9.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.81 | 200-d Avg | 4.77 | 1yr Est | 33.00 |
| Income Statement | |||
| Operating Expenses | 1.30M | ||
| Research and Development Expense | 702.00K | ||
| Selling, General and Administrative Expense | 597.00K | ||
| Operating Income | -1.30M | ||
| Interest Expense | 9.00K | ||
| Net Income | -441.00K | ||
| Net Income Common Stock | -441.00K | ||
| Net Income Common Stock (USD) | -441.00K | ||
| Consolidated Income | -441.00K | ||
| Earnings per Basic Share | -0.40 | ||
| Earnings per Basic Share (USD) | -0.40 | ||
| Earnings per Diluted Share | -0.40 | ||
| Earning Before Interest & Taxes (EBIT) | -432.00K | ||
| Earning Before Interest & Taxes (USD) | -432.00K | ||
| Weighted Average Shares | 2.17B | ||
| Weighted Average Shares Diluted | 2.17B | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.24M | ||
| Cash and Equivalents (USD) | 5.24M | ||
| Investments | 869.00K | ||
| Investments Current | 869.00K | ||
| Current Assets | 6.59M | ||
| Property, Plant & Equipment Net | 216.00K | ||
| Total Assets | 14.17M | ||
| Debt Current | 134.00K | ||
| Total Debt | 134.00K | ||
| Current Liabilities | 1.78M | ||
| Total Liabilities | 1.95M | ||
| Accumulated Retained Earnings (Deficit) | -170.72M | ||
| Shareholders Equity | 12.27M | ||
| Shareholders Equity (USD) | 12.27M | ||
| Assets Non-Current | 7.58M | ||
| Total Debt (USD) | 134.00K | ||
| Goodwill and Intangible Assets | 7.36M | ||
| Liabilities Non-Current | 170.00K | ||
| Trade and Non-Trade Payables | 1.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 70.00K | ||
| Net Cash Flow from Financing | 2.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -384.00K | ||
| Capital Expenditure | -3.00K | ||
| Issuance (Purchase) of Equity Shares | 2.30M | ||
| Issuance (Repayment) of Debt Securities | -66.00K | ||
| Net Cash Flow from Investing | 1000 | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -14.00K | ||
| Net Cash Flow from Operations | -2.50M | ||
| Effect of Exchange Rate Changes on Cash | 43.00K | ||
| Share Based Compensation | 67.00K | ||